{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11006",
      "entity_text" : "CNS",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q66K79",
      "entity_text" : "CPZ",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In order to investigate the role of CX 3 CL1/CX 3 CR1 signaling during the inflammatory phase of CPZ induced CNS demyelination, six experimental mouse groups were included in two independent experiments, and shown here are the pooled data from (a) wild type CX 3 CR1 +/+ C57BL/6 mice at the age of 12 weeks (n = 7), (b) wild type CX 3 CR1 +/+ C57BL/6 mice at the age of 12 weeks that received a 0.2% CPZ supplemented diet between the age of 8 and 12 weeks (n = 7), (c) transgenic CX 3 CR1 +/- C57BL/6 mice, in which one copy of the CX3CR1 gene is replaced by the eGFP reporter gene, at the age of 12 weeks (n = 7), (d) transgenic CX 3 CR1 +/- C57BL/6 mice at the age of 12 weeks that received a 0.2% CPZ supplemented diet between the age of 8 and 12 weeks (n = 8), (e) transgenic CX 3 CR1 -/- C57BL/6 mice, in which both copies of the CX 3 CR1 gene are replaced by the eGFP reporter gene, at the age of 12 weeks (n = 7) and (f) transgenic CX 3 CR1 +/- C57BL/6 mice at the age of 12 weeks that received a 0.2% CPZ supplemented diet between the age of 8 and 12 weeks (n = 7).",
  "reading_complete" : "2020-08-04T15:15:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:13:53Z",
  "trigger" : "induced",
  "evidence" : [ "CPZ-induced CNS" ],
  "pmc_id" : "4403969",
  "score" : 0
}